title: [Characteristics of central nervous system activity in patients with complications of arterial hypertension and dependence on psychomotor status and treatment].
abstract: Changes in certain CNS characteristics were used as indicators of the efficacy of antihypertensive therapy (AHT) both targeted (T-AHT) and empirical (E-AHT) designed to suppress activity of the sympathetic component of vegetative nervous system (VNS) and renin-angiotensin-aldosterone system (RAAS) in patients of different psychic status and AH. A group of 835 men (mean age 54.2+-1.8yr) was divided into cholerics, sanguinics, melancholics and phlegmatics with a high and low anxiety level (HA and LA). 416 healthy men served as controls. The following parameters were estimated: mobility of cortical processes, balance between sympathetic and parasympathetic activities, blood corrisol and aldosterone levels, oxygen utilization coefficient, resistance to breath holding, severity of dyscirculatory encephalopathy and the fraction of patients with AH complications during 12 month T-AHT for the suppression of sympathetic activity in cholerics and sanguinics by beta-adrenoblockers and PAA C- ACE inhibitors in phlegmatics and melancholics and during E-AHT (ACE inhibitors in cholerics and sanguinics, BAB in phlegmatics and melancholics). The functional activity of CNS in phlegmatics and melancholics before and during AHT was lower and severity of encephalopathy and the number ofAH complications higher than in cholerics and sanguinics. . The changes wiere more pronounced in patients with HA than in those with LA. Unlike E-AHT T-AHT (anxiolytics for cholerics and sanguinics with HA, antidepressants for phlegmatics and melancholics with HA) normalized the study parameters and decreased the frequency of complications by 2-3 times.
authors.forename: A G
authors.initials: AG
authors.lastname: Usenko
authors.forename: N P
authors.initials: NP
authors.lastname: Velichko
authors.forename: G A
authors.initials: GA
authors.lastname: Usenko
authors.forename: O V
authors.initials: OV
authors.lastname: Nishcheta
authors.forename: T Iu
authors.initials: TIu
authors.lastname: Kozyreva
authors.forename: A A
authors.initials: AA
authors.lastname: Demin
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000145:classification*; D002490:Central Nervous System / Q000187:drug effects / Q000503:physiopathology*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology*; D008297:Male; D008875:Middle Aged; D011597:Psychomotor Performance / Q000145:classification / Q000187:drug effects; D012720:Severity of Illness Index; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology; D013694:Temperament / Q000145:classification*; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents